Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 23, 2015

Primary Completion Date

August 22, 2017

Study Completion Date

December 17, 2019

Conditions
Polypoidal Choroidal Vasculopathy
Interventions
DRUG

Intravitreal Aflibercept

Trial Locations (13)

4710-243

Hospital de Braga, Braga

3000-548 Coimbra

AIBILI - Centro de Ensaios Clínicos, Coimbra

3030-163

Espaço Médico de Coimbra, Coimbra

2400-171

Centro Hospitalar de Leiria, Leiria

1050-085 Lisboa

IRL - Instituto de Retina e Diabetes de Lisboa, Lisbon

1649-035

Centro Hospitgalar de Lisboa Norte, EPE - Hospital de Santa Maria, Lisbon

Unknown

Instituto de Oftalmologia Dr. Gama Pinto, Lisbon

Bellvitge University Hospital, Barcelona

Instituto de Microcirugia Ocular, Barcelona

Vall d'Hebron Hospital, Barcelona

Hospital Insular de Gran Canaria, Las Palmas

4099-001

Centro Hospitalar do Porto- Hospital de Santo António, Porto

4200-319

Centro Hospitalar de São João, EPE - Serviço de Oftalmologia, Porto

All Listed Sponsors
collaborator

European Vision Institute Clinical Research Network

NETWORK

lead

Association for Innovation and Biomedical Research on Light and Image

OTHER